Hardy Forzley was Appointed as Chief Financial Officer at Pascal-Biosciences

Date of management change: June 16, 2021 

What Happened?

Vancouver, BC-based Pascal-Biosciences Appointed Hardy Forzley as Chief Financial Officer

 

About the Company

Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company`s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.

 

About the Person

Hardy Forzley is Chief Financial Officer at Pascal Biosciences. Previously, Hardy held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Graves Patrice, Horn Juergen, Elder Marnese, Tack Steve, Keliher Marty, Castronovo Loren, Sinha Abhishek, Perkins Milton, Endres Kellie, Taylor Cheryl, Childs Mark

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.